Voloridge Investment Management, LLC Compugen LTD Transaction History

Voloridge Investment Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$4.09 - $7.16 $978,683 - $1.71 Million	-239,287 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$5.8 - $8.02 $640,697 - $885,929	-110,465 Reduced 31.58%	239,287 $1.43 Million
Q2 2021 Aug 16, 2021	SELL	$6.87 - $9.16 $1.03 Million - $1.38 Million	-150,467 Reduced 30.08%	349,752 $2.9 Million
Q1 2021 May 17, 2021	BUY	$7.67 - $13.77 $3.66 Million - $6.57 Million	477,384 Added 2090.58%	500,219 $4.3 Million
Q4 2020 Feb 16, 2021	BUY	$12.07 - $17.95 $275,618 - $409,888	22,835 New	22,835 $277,000

13.3M

191K

135K

Ticker CGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 86,624,600
Market Cap $142M
Description
Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. The company's immuno-oncology pipeline consists of COM701, an anti-PVRIG antibody that is in Phase I clinical study used for the treatment of solid tu...

Get notified when there are updates to the investment portfolio of Voloridge Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Voloridge Investment Management, LLC with notifications on news.